Package Leaflet: Information for the Patient
Oxicodona Sandoz 40 mg prolonged-release tablets EFG
oxycodone hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Oxicodona Sandoz contains the active substance oxycodone hydrochloride, which is a strong analgesic of the opioid group, acting centrally.
Oxicodona Sandoz is used in adults and adolescents over 12 years for the treatment of severe pain, which can only be relieved with opioid analgesics.
Consult your doctor or pharmacist before starting to take oxycodone if
Tell your doctor if you have or have had any of the conditions mentioned above.
Contact your doctor if you have severe abdominal pain that may radiate to the back, nausea, vomiting, or fever, as these may be symptoms associated with pancreatitis and biliary tract disease.
Sleep-related breathing disorders
Oxicodona Sandoz may cause sleep-related breathing disorders such as sleep apnea and sleep-related hypoxemia. Symptoms may include pauses in breathing during sleep, nighttime awakenings due to difficulty breathing, difficulty maintaining sleep, or excessive daytime sleepiness. If you or someone else observes these symptoms, consult your doctor. Your doctor may consider reducing the dose.
Respiratory depression
The main danger of an overdose with opioids is slow and shallow breathing (respiratory depression). This occurs especially in weak and elderly patients and can also cause a decrease in oxygen levels in the blood. This can cause, for example, fainting.
Non-cancer chronic pain
Opioids are not the first choice for treating non-cancer pain and are not recommended as the only treatment. In the treatment of chronic pain, other medications should be used along with opioids. Your doctor should closely monitor you and make the necessary adjustments to your dose while you are taking oxycodone to prevent addiction and abuse.
Oxycodone can cause dependence. When used for a long period, tolerance to its effects may occur, and higher doses may be needed to maintain pain control.
Chronic use of oxycodone can lead to physical dependence, and withdrawal symptoms may occur after sudden interruption (see section 3, "If you stop taking Oxicodona Sandoz"). Withdrawal symptoms may include yawning, pupil dilation, abnormal or excessive tear secretion, runny nose, tremors or agitation, increased sweating, anxiety, agitation, seizures, insomnia, and muscle pain. When therapy with oxycodone is no longer necessary, your doctor will gradually reduce your daily dose to avoid this.
Tolerance, dependence, and addiction
This medicine contains oxycodone, which is an opioid, and can cause dependence and/or addiction. |
This medicine contains oxycodone, which is an opioid medication. Repeated use of opioid analgesics can make the medication less effective (you get used to it, which is known as tolerance).
Repeated use of Oxicodona Sandoz can also cause dependence, abuse, and addiction, which can lead to a life-threatening overdose. The risk of these side effects may increase with higher doses and longer use.
Dependence or addiction can make you feel like you no longer have control over the amount of medication you need to take or how often you need to take it. You may feel like you need to keep taking the medication even when it no longer helps relieve your pain.
The risk of becoming dependent or addicted varies from person to person. You may have a higher risk of becoming dependent or addicted to Oxicodona Sandoz if:
If you notice any of the following signs while taking Oxicodona Sandoz, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, talk to your doctor to discuss the best treatment for you, including when it is appropriate to stop taking it and how to do so safely (see section 3, "If you stop taking Oxicodona Sandoz").
The prolonged-release tablets should be administered with special caution in patients with a history of drug and alcohol abuse.
Increased sensitivity to pain
An increase in pain sensitivity (hyperalgesia) may occur, which will not respond to an additional increase in the dose of oxycodone, especially at high doses. It may be necessary to reduce the dose of oxycodone or switch to an alternative opioid.
In the case of abusive injection (intravenous injection), the excipients of the tablet can cause destruction (necrosis) of local tissue, changes in lung tissue (granulomas in the lung), or other potentially fatal serious effects.
Like other opioids, oxycodone can affect the normal production of hormones in the body, such as cortisol or sex hormones, particularly if you are taking high doses for long periods.
You may see residues of the tablet in your feces. Do not worry, as the active substance oxycodone hydrochloride has already been released while the tablet passed through your gastrointestinal system and has started to take effect in your body.
Athletes should be aware that this medication may produce a positive result in anti-doping tests.
The use of oxycodone as a doping agent can be a health hazard.
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Taking oxycodone at the same time as certain medications that affect brain function (see below) can increase the risk of stopping breathing, especially in cases of overdose in elderly patients, and/or increase the sedative effect of oxycodone (you may feel very drowsy).
The concomitant use of oxycodone and medications that may affect brain function (e.g., sedative medications such as benzodiazepines or related medications, see below) increases the risk of drowsiness, difficulty breathing (respiratory depression), coma, and can be potentially fatal. Due to this, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor prescribes oxycodone along with sedative medications, your doctor should limit the dose and duration of concomitant treatment. Tell your doctor about all sedative medications you are taking and follow your doctor's recommended doses carefully. It may be helpful to inform friends or family members to be aware of the signs and symptoms indicated above. Contact your doctor when you experience these symptoms.
Medications that affect brain function:
The risk of side effects increases if you are taking antidepressants (such as citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, venlafaxine). These medications can interact with oxycodone and may cause symptoms such as involuntary muscle contractions, including muscles that control eye movements, agitation, excessive sweating, tremors, exaggerated reflexes, increased muscle tension, and body temperature above 38 °C. Contact your doctor if you experience these symptoms.
Other interactions may occur with:
Drinking alcohol during treatment with oxycodone can make you feel drowsy or increase the risk of serious side effects such as shallow breathing and loss of consciousness. It is recommended not to drink alcohol while taking oxycodone.
Drinking grapefruit juice while taking oxycodone can increase the risk of adverse reactions. You should avoid drinking grapefruit juice during treatment with oxycodone.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take oxycodone during pregnancy. There are limited data on the use of Oxicodona Sandoz in pregnant women.
Oxycodone crosses the placenta into the baby's bloodstream.
Prolonged use of oxycodone during pregnancy may cause withdrawal symptoms in the newborn. The use of oxycodone during delivery may cause slow and shallow breathing (respiratory depression) in the newborn.
You should not take Oxicodona Sandoz if you are breastfeeding, as the active substance oxycodone may pass into breast milk and cause drowsiness (sedation) or slow and shallow breathing (respiratory depression) in the infant.
Oxycodone can affect your ability to drive and use machines.
In patients who are stabilized on a specific dose, it may not affect driving restrictions. Your doctor will make this decision based on your individual case. Consult your doctor about when, or under what conditions, you can drive a vehicle.
Oxicodona Sandoz contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.
Before starting treatment and periodically during treatment, your doctor will talk to you about what you can expect from the use of Oxicodona Sandoz, when and for how long you should take it, when to contact your doctor, and when to stop taking it (see also "If you stop taking Oxicodona Sandoz").
Other concentrations of this medicine may be available for dose adjustment.
Adults and adolescents (12 years and older)
The usual initial dose is 10 mg of oxycodone hydrochloride at 12-hour intervals. Your doctor will indicate the necessary dose to treat the pain.
Take the determined number of prolonged-release tablets twice a day, as directed by your doctor.
The subsequent determination of the daily dose, the division into individual doses, and any dose adjustment during the subsequent course of treatment should be carried out by the treating physician, taking into account previous doses.
Patients who have already taken opioids may start treatment with higher doses, considering their previous experience.
Some patients who receive oxycodone prolonged-release tablets on a fixed schedule need fast-acting analgesics as rescue medication to control breakthrough pain. Oxycodone prolonged-release tablets are not indicated for the treatment of breakthrough pain.
For the treatment of non-cancer pain, a daily dose of 40 mg of oxycodone hydrochloride is generally sufficient, but higher doses may be necessary.
Patients with cancer-related pain usually require daily doses of 80 to 120 mg of oxycodone hydrochloride, which in some cases can be increased up to 400 mg.
During treatment, pain relief and other effects should be regularly monitored to achieve the best possible pain treatment, as well as to be able to treat any adverse effects that occur as soon as possible, and to decide whether to continue treatment.
Children under 12 years
This medication has not been studied in children under 12 years of age. Therefore, its safety has not been demonstrated, and its use is not recommended in children.
Patients with renal and/or hepatic insufficiency
Your doctor may prescribe a lower initial dose.
Other patients at risk
Your doctor may prescribe a lower initial dose if you have a low body weight or if you metabolize medications more slowly.
Method of administration
Oral use only.
Swallow the prolonged-release tablets whole with a sufficient amount of liquid (half a glass of water), with or without food, in the morning and in the evening, following a fixed schedule (e.g., at 8 am and 8 pm).
The prolonged-release tablets should not be divided, broken, crushed, or chewed, as this can lead to rapid release of oxycodone due to alteration of the prolonged-release properties. Administration of broken, chewed, or crushed tablets can lead to rapid release and absorption of a potentially fatal dose of the active ingredient oxycodone (see the section "If you take more Oxicodona Sandoz than you should").
Oxycodone is for oral administration only. In case of abusive injection (intravenous injection), the excipients of the tablet can cause destruction (necrosis) of local tissues, changes in lung tissue (granulomas in the lung), or other serious and potentially fatal effects.
If you have taken more oxycodone than you should, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Symptoms of overdose may be:
In severe cases, loss of consciousness (coma), fluid accumulation in the lungs, and circulatory collapse may occur, which can be fatal.
Never expose yourself to situations that require a high degree of concentration, such as driving.
If you use a lower dose of oxycodone than prescribed, or forget to take the tablets, pain relief will be insufficient, or will cease completely.
If you forget to take a dose, please follow these instructions:
Do not take more than one dose in an 8-hour period.
Do not take a double dose to make up for forgotten doses.
Do not interrupt treatment without consulting your doctor first.
When a patient no longer needs treatment with oxycodone, it may be advisable to gradually decrease the dose to prevent withdrawal symptoms (e.g., yawning, pupil dilation, lacrimation, nasal secretion, tremors, sweating, anxiety, restlessness, convulsions, difficulty sleeping, or muscle pain).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not all people experience them.
The most common adverse effects are nausea (especially at the beginning of therapy) and constipation. Constipation as an adverse effect can be counteracted with preventive measures (such as drinking plenty of fluids, a fiber-rich diet). If you experience nausea or vomiting, your doctor may prescribe a medication.
Important adverse effects or signs that you should be aware of and what to do if you are affected:
Stop taking oxycodone and consult your doctor or go to your nearest emergency center immediately if you experience any of the following symptoms:
Possible adverse effects
Very common(may affect more than 1 in 10 people),
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children. Store this medication in a safe and closed place, where other people cannot access it. It can cause serious harm and be fatal for people when not prescribed to them.
Do not use this medication after the expiration date that appears on the blister, bottle, and packaging after "EXP". The expiration date is the last day of the month indicated.
No special storage conditions are required.
Bottles: Expiration after first opening:
6 months.
Medications should not be thrown away through the sewers or in the trash. Deposit the packaging and medications you no longer need in the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Each prolonged-release tablet contains 40 mg of oxycodone hydrochloride, equivalent to 35.9 mg of oxycodone.
Core of the tablet:hydrogenated ricin oil, copovidone, behenoyl polyoxylglycerides, lactose monohydrate, magnesium stearate, corn starch, anhydrous colloidal silica, medium-chain triglycerides.
Prolonged-release tablets, film-coated, yellow, round, biconvex, 6.8 - 7.4 mm in diameter.
The prolonged-release tablets are packaged in child-resistant blisters or in bottles with a child-resistant Twist-off cap, with or without a desiccant capsule, containing silica gel as a desiccant.
Package sizes:
Blister: 10, 20, 28, 30, 40, 50, 56, 60, 100, and 112 prolonged-release tablets.
Bottles: 50 and 100 prolonged-release tablets.
Not all package sizes may be marketed.
Marketing authorization holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Lek Pharmaceuticals d.d
Verovskova 57,
1526 Ljubljana
Slovenia
or
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben
Germany
Germany: Oxycodonhydrochlorid - 1 A Pharma 40 mg Retardtabletten
Belgium: Oxycodon Sandoz 40 mg tabletten met verlengde afgifte
Denmark: Oxycodone Depot Sandoz
Netherlands: Oxycodon HCl Sandoz retard 40mg, tabletten met verlengde afgifte
Sweden: Oxycodone Depot 1A Farma 40 mg depottabletter
Slovenia: Codilek 40 mg tablete s podaljšanim sprošcanjem
Slovakia: Contiroxil 40 mg tablety s predlženým uvolnovaním
United Kingdom
Northern Ireland: Carexil 40 MG Prolonged-release Tablets
Date of last revision of this leaflet:April 2025.
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of OXYCODONE SANDOZ 40 mg PROLONGED-RELEASE TABLETS in October, 2025 is around 27.29 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.